Merrimack Common Stock Total Equity from 2010 to 2024
| MACK Stock | USD 14.73 0.02 0.14% |
Common Stock Total Equity | First Reported 2010-12-31 | Previous Quarter 1.3 M | Current Value 1.3 M | Quarterly Volatility 397.4 K |
Check Merrimack Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merrimack main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.1 K, Total Revenue of 0.0 or Other Operating Expenses of 2.1 M, as well as many exotic indicators such as Price To Sales Ratio of 3.05, Dividend Yield of 0.31 or PTB Ratio of 10.74. Merrimack financial statements analysis is a perfect complement when working with Merrimack Pharmaceuticals Valuation or Volatility modules.
Merrimack | Common Stock Total Equity |
Latest Merrimack Pharmaceuticals' Common Stock Total Equity Growth Pattern
Below is the plot of the Common Stock Total Equity of Merrimack Pharmaceuticals over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Merrimack Pharmaceuticals' Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merrimack Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Common Stock Total Equity | 10 Years Trend |
|
Common Stock Total Equity |
| Timeline |
Merrimack Common Stock Total Equity Regression Statistics
| Arithmetic Mean | 2,270,236 | |
| Geometric Mean | 1,280,699 | |
| Coefficient Of Variation | 184.60 | |
| Mean Deviation | 2,012,502 | |
| Median | 1,334,000 | |
| Standard Deviation | 4,190,943 | |
| Sample Variance | 17.6T | |
| Range | 17.2M | |
| R-Value | (0.37) | |
| Mean Square Error | 16.3T | |
| R-Squared | 0.14 | |
| Significance | 0.17 | |
| Slope | (349,318) | |
| Total Sum of Squares | 245.9T |
Merrimack Common Stock Total Equity History
About Merrimack Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Merrimack Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Merrimack Pharmaceuticals investors use historical funamental indicators, such as Merrimack Pharmaceuticals's Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Although Merrimack Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Merrimack Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Merrimack Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Merrimack Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Merrimack Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Common Stock Total Equity | 1.2 M | 1.8 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Merrimack Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Merrimack Pharmaceuticals' short interest history, or implied volatility extrapolated from Merrimack Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Merrimack Pharmaceuticals Correlation against competitors. For more information on how to buy Merrimack Stock please use our How to buy in Merrimack Stock guide.Note that the Merrimack Pharmaceuticals information on this page should be used as a complementary analysis to other Merrimack Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Merrimack Stock analysis
When running Merrimack Pharmaceuticals' price analysis, check to measure Merrimack Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merrimack Pharmaceuticals is operating at the current time. Most of Merrimack Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Merrimack Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merrimack Pharmaceuticals' price. Additionally, you may evaluate how the addition of Merrimack Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Merrimack Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merrimack Pharmaceuticals. If investors know Merrimack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merrimack Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.08) | Return On Assets (0.07) | Return On Equity (0.06) |
The market value of Merrimack Pharmaceuticals is measured differently than its book value, which is the value of Merrimack that is recorded on the company's balance sheet. Investors also form their own opinion of Merrimack Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Merrimack Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merrimack Pharmaceuticals' market value can be influenced by many factors that don't directly affect Merrimack Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merrimack Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Merrimack Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merrimack Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.